Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 26 % of short-term debt in 2026; threshold 65 %.
Financials
Financial year 2026
VVM Pharma Invest from Waregem, company number BE0536716836, closed financial year 2026 with a result of € 209,582 after tax. For that financial year VVM Pharma Invest recorded a gross margin of € 180,523 and equity of € 745,240. Compared with financial year 2025, the result moved from € 159,987 to € 209,582. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 8, 2026.
€ 745,240
▲ 2% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 209,582
▲ 31% vs 2025
Profit after tax over the fiscal year.
€ 47,256
▲ 11% vs 2025
Cash and bank balances on the last day of the fiscal year.
€ 196,000 paid out
94 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2026
€ 36,702
▼ 33% vs 2025
Book value of vehicles, furniture and equipment.
Debts at end 2026
€ 826,999
▼ 8% vs 2025
€ 113,007 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 2,188
▼ 85% vs 2025
Supplier invoices still open on the last day of the fiscal year.
€ 12,455
▲ 16% vs 2025
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € 202,675 | € 178,607 | € 175,316 | € 180,523 | ▲ 3% |
| Profit after taxes | € 156,551 | € 190,070 | € 159,987 | € 209,582 | ▲ 31% |
| Equity | € 431,600 | € 571,670 | € 731,658 | € 745,240 | ▲ 2% |
| Total debts | € 1,252,574 | € 1,173,734 | € 961,428 | € 915,828 | ▼ 5% |
| Cash | € 75,706 | € 54,694 | € 42,697 | € 47,256 | ▲ 11% |
| Land & buildings | € 666,096 | € 633,814 | € 610,205 | € 600,575 | ▼ 2% |
| Retained profit | € 412,994 | € 553,064 | € 713,052 | € 726,634 | ▲ 2% |
| Dividend | € 120,000 | € 50,000 | € 0 | € 196,000 | |
| Bank debt | € 1,123,517 | € 1,106,529 | € 902,010 | € 826,999 | ▼ 8% |
| Balance sheet total | € 1,684,174 | € 1,745,404 | € 1,693,086 | € 1,661,068 | ▼ 2% |
By gross margin, VVM Pharma Invest ranks 8th of 11 companies with main activity “Detailhandel in farmaceutische producten” in Waregem that publish figures (fiscal year 2026).
Key figures of VVM Pharma Invest, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
Ask about VVM Pharma Invest the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to VVM Pharma Invest?
What happened at VVM Pharma Invest in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 209,582 (▲ 31% vs 2025). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Waregem. KBO
In short
From € 156,551 profit in 2023 to € 209,582 profit in 2026.
Paid € 146,151 in corporate taxes since 2023.
Best year ever: 2026, with € 209,582 profit.
Paid out € 366,000 in dividends to the owners in total.
Management
Behind VVM Pharma Invest are Stefaan Van Meel and Sebastien Verhofstede. It owns 100% of Apotheek Verhofstede itself.
Directors
According to the 2026 annual accounts
Establishments
Establishment units
Physical locations of this company
Zuiderlaan 35 box 94
8790 Waregem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Waregem
Same main activity (Detailhandel in farmaceutische producten), 13 active companies in Waregem, largest first.
€ 568,117 gross margin · 2025
€ 404,373 gross margin · 2025
€ 373,490 gross margin · 2025
€ 325,989 gross margin · 2025
€ 283,108 gross margin · 2025
€ 207,649 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- VERHOFSTEDE, Sebastien Hélène Marie Eric Joseph(oprichter) 99%
- VAN MEEL, Stefaan Jozef Fabienne(oprichter) 1%
Details
- Company number
- 0536.716.836
- VAT number
- BE 0536.716.836
- Registered office
- Zuiderlaan 35 bus 94, 8790 Waregem
- Names & denominations
- VVM Pharma Invest
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 July 2013
- Peppol
- Active · Active since 26 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten